Oct 19, 2021 2:00 am EDT NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays
Oct 13, 2021 4:20 pm EDT NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021
Sep 9, 2021 7:00 am EDT NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR(TM) MRD and InVisionFirst(R)-Lung Assays at the ESMO Congress 2021
Sep 1, 2021 4:05 pm EDT NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
Jul 14, 2021 4:05 pm EDT NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021
Jun 18, 2021 7:30 am EDT NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
May 27, 2021 4:05 pm EDT NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences
